GLF
AZN icon

Groupe la Francaise’s AstraZeneca AZN Stock Holding History

Groupe la Francaise’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$152M Sell
810,732
-173,876
-18% -$32.7M 1.83% 11
2026
Q1 		$191M Buy
+984,608
New +$190M 2.62% 8
2025
Q4 		– Sell
-65
Closed -$8.21K – 487
2025
Q3 		$8.21K Buy
+65
New +$9.84K ﹤0.01% 585

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Groupe la Francaise's AZN Position: Q2 2026 in Review

Groupe la Francaise reduced its AstraZeneca (AZN) stake by 18% in Q2 2026, selling an estimated $32.7M and leaving 810,732 shares worth $152M. The position accounts for 1.83% of the portfolio, ranked #11.

Groupe la Francaise first reported a position in AZN in Q3 2025 and has held it in 3 quarters since. The position peaked at $191M in Q1 2026. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Groupe la Francaise held 810,732 shares of AstraZeneca worth $152M as of Q2 2026.
  • Groupe la Francaise sold 173,876 AstraZeneca shares in Q2 2026, an estimated $32.7M.
  • AstraZeneca made up 1.83% of Groupe la Francaise's portfolio in Q2 2026, its #11 holding.
  • Groupe la Francaise first reported a position in AstraZeneca in Q3 2025 and has held it in 3 quarters since.
  • Groupe la Francaise's AstraZeneca position peaked at $191M in Q1 2026.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.